Demand Forecasting
Projected demand based on order history
7 product(s) recommended for reorder based on projected demand.
Units — Avg Monthly vs Projected
BPC-157 5mg
Avg: 25.0/moProjected: 28.0
Stock: 170OK
2026-09
Semaglutide 5mg
Avg: 15.0/moProjected: 18.0
Stock: 45OK
2026-09
NAD+ 500mg
Avg: 20.0/moProjected: 24.0
Stock: 0Reorder · 100
2026-09
GHK-Cu 50mg
Avg: 12.0/moProjected: 14.0
Stock: 12Reorder · 100
2026-09
CJC-1295/Ipamorelin 5mg
Avg: 18.0/moProjected: 21.0
Stock: 95OK
2026-09
Tirzepatide 5mg
Avg: 8.0/moProjected: 10.0
Stock: 0Reorder · 100
2026-09
TB-500 5mg
Avg: 16.0/moProjected: 18.0
Stock: 0Reorder · 100
2026-09
Epitalon 10mg
Avg: 10.0/moProjected: 12.0
Stock: 0Reorder · 100
2026-09
MOTS-c 10mg
Avg: 9.0/moProjected: 11.0
Stock: 0Reorder · 100
2026-09
Copper Peptide Serum 30mL
Avg: 14.0/moProjected: 16.0
Stock: 0Reorder · 100
2026-09
| Product | Avg Monthly | Projected Next Month | Current Stock | Reorder Rec. | Rec. Qty | Period |
|---|---|---|---|---|---|---|
| BPC-157 5mg | 25.0 | 28.0 | 170 | No | — | 2026-09 |
| Semaglutide 5mg | 15.0 | 18.0 | 45 | No | — | 2026-09 |
| NAD+ 500mg | 20.0 | 24.0 | 0 | Yes | 100 | 2026-09 |
| GHK-Cu 50mg | 12.0 | 14.0 | 12 | Yes | 100 | 2026-09 |
| CJC-1295/Ipamorelin 5mg | 18.0 | 21.0 | 95 | No | — | 2026-09 |
| Tirzepatide 5mg | 8.0 | 10.0 | 0 | Yes | 100 | 2026-09 |
| TB-500 5mg | 16.0 | 18.0 | 0 | Yes | 100 | 2026-09 |
| Epitalon 10mg | 10.0 | 12.0 | 0 | Yes | 100 | 2026-09 |
| MOTS-c 10mg | 9.0 | 11.0 | 0 | Yes | 100 | 2026-09 |
| Copper Peptide Serum 30mL | 14.0 | 16.0 | 0 | Yes | 100 | 2026-09 |